UPLOAD Filing
PLUS THERAPEUTICS, INC.
Date: June 13, 2025 · CIK: 0001095981 · Accession: 0000000000-25-006276
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Plus Therapeutics, Inc. Draft Registration Statement on Form S-1 Submitted June 9, 2025 CIK No. 0001095981 Dear Andrew Sims:
June 13, 2025
Andrew Sims Chief Financial Officer Plus Therapeutics, Inc. 2710 Reed Road, Suite 160 Houston, TX 77002
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Aaron Schleicher
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 13, 2025 Andrew Sims Chief Financial Officer Plus Therapeutics, Inc. 2710 Reed Road, Suite 160 Houston, TX 77002 Re: Plus Therapeutics, Inc. Draft Registration Statement on Form S-1 Submitted June 9, 2025 CIK No. 0001095981 Dear Andrew Sims: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Aaron Schleicher </TEXT> </DOCUMENT>